This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Feline Atopic Dermatitis Treatment Market

Market Insights on Feline Atopic Dermatitis Treatment covering sales outlook, demand forecast & up-to-date key trends

Feline Atopic Dermatitis Treatment Market by Drug Class, Route of Administration & Region - Forecast 2022 – 2032

Feline Atopic Dermatitis Treatment Market Snapshot (2022-2032)

[250 Pages Report] The global feline atopic dermatitis treatment market is slated to expand at a positive 4.5% CAGR during the assessment period (2022-2032). Sales in the feline atopic dermatitis treatment market are expected to reach US$ 5 Bn by the end of 2022. Growth in the market is primarily attributed to the rising adoption of cats as a companion pet across the globe.

Report Attribute

Details

Feline Atopic Dermatitis Treatment Market Estimated Growth Rate (2022-2032)

4.5% CAGR

Feline Atopic Dermatitis Treatment Market Estimated Size (2022)

US$ 5 Bn

Feline Atopic Dermatitis Treatment Market Projected Size (2032)

US$ 7 Bn

Atopic dermatitis is the inflammation of skin witnessed in cats and is caused by causative allergens, which are either inhaled or caused by skin contact. With rising adoption of cats as pet, the prevalence of feline atopic dermatitis is surging across the globe.

According to Canadian Veterinary Journal, prevalence of atopic dermatitis in cats was reported to be over 12.5% in feline. As atopy causes distress, fur loss, and discomfort in cats, the need for feline atopic dermatitis treatment is expected to burgeon over the forecast period.

To curb the rising incidence of atopy in cats, professionals are using steroids and antibiotics to reduce the itchiness and fur loss. As steroids are cost-effective and effective, the corticosteroids segment is expected to gain traction, as per Future Market Insights (FMI).

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Trends Boosting the Feline Atopic Dermatitis Treatment Market?

One of the primary factors driving the growth in the market is rising adoption of companion animals such as dogs and cats across the globe. According to the National Kitten Coalition statistics, around 1.3 million cats are adopted every year as pets across the globe.

With rising adoption of cats, prevalence of skin allergies and other diseases in feline will improve the demand for feline atopic dermatitis treatments. Besides this, increasing number of veterinarians in developed regions such as North America and Europe will further spur the growth in the market.

Which are the Factors Restricting the Demand in Feline Atopic Dermatitis Treatment Market?

With increasing number of pet adoption across the globe, prevalence of several animal diseases is also surging. Every year over 7.6 million companion animals such as cats and dogs enter shelter across the globe. Among which, over 3.4 million felines are adopted, as per the National Kitten Coalition.

However, lack of novel treatment in emerging economies such as Brazil, Argentina, India, and others might limit the growth in the market. Due to the lack of treatment, the chance of reoccurrence of atopic dermatitis is high. This might hamper the feline atopic dermatitis treatment market.

Another factor hampering the demand in the market is treatment cost of feline atopic dermatitis treatment. As per the study, the cost of this treatment is generally high, which might affect the sales in Latin America and Middle East & Africa.

Additionally, long-term side-effects of corticosteroids might limit the sales of oral treatment. This is expected to hinder the growth in the market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Demand Outlook for Asia Pacific Feline Atopic Dermatitis Treatment Market?

Asia Pacific feline atopic dermatitis treatment market is anticipated to witness modest growth between 2022 and 2032, opines Future Market Insights (FMI). Asia Pacific is considered to be the emerging feline atopic dermatitis market owing to the rising pet ownership of cats and dogs in India, China, and Japan.

As per FMI, India is expected to spearhead the growth in Asia Pacific market over the forecast period. This is due to the increasing number of veterinarians in the country coupled with rising adoption of cats. Moreover, rise in the number of research organizations to develop novel medicines and treatment procedures in China will boost the market.

Further, greater penetration of leading players in India and adequate availability of treatment for pet animals will improve the demand in Asia Pacific market over the upcoming decade.

What Makes North America the Most Lucrative Feline Atopic Dermatitis Treatment Market?

As per FMI, the U.S. is expected to account for significant share in North America feline atopic dermatitis treatment market. Around 1.9 million pets were adopted in 2020 across the U.S., according to the Pet Adoption Statistics. Out of which, there were 1.1 million cats and the number is projected to increase over the coming decade.

With growth in the number of pet adoption, prevalence of skin treatment among feline is also surging. This is expected to create lucrative growth opportunities for feline atopic dermatitis treatment market in North America.

Further, availability of reimbursement policies, growing number of veterinarians, and early adoption of novel medication and treatment in the U.S. will propel the demand in the North America market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Competition

Some of the leading manufacturers of feline atopic dermatitis treatment include Bayer AG, Pfizer Inc., Boehringer Ingelheim International GmbH Novartis AG, Eli Lily Company, Sanofi, Bristol-Myers Squibb Company, and Bausch Health Companies Inc. among others.

Key players in the feline atopic dermatitis treatment market are relying on merges and collaborative agreements to increase their revenue. They are also investing in research and development activities to develop novel treatments and medicines to expand their product portfolio.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 4.5% from 2022 to 2032

Estimated Market Size (2022)

~US$ 5 Bn 

Projected Market Size (2032)

~US$ 7 Bn

Base Year for Estimation

2021

Historical Data

2015-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Drug Class
  • Route of Administration
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

Customization

Available Upon Request

Key Segments Profiled in the Feline Atopic Dermatitis Treatment Industry Survey

By Drug Class:

  • Corticosteroids
  • Antihistamines
  • Antibiotics

By Route of Administration:

  • Oral
  • Topical
  • Injectable

By Distribution Channel:

  • Veterinary Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • Japan
  • Middle East and Africa

Frequently Asked Questions

As per FMI, the global feline atopic dermatitis treatment market demand is slated to increase at 4.5% CAGR during the forecast period.

North America is anticipated to dominate the global feline atopic dermatitis treatment market over the forecast period (2022-2032).

Overall demand in the feline atopic dermatitis treatment market is expected to exceed US$ 5 Bn by the end of 2022.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. Value Chain Analysis

        3.5.1. Profit Margin Analysis

        3.5.2. Service Providers

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Class

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Drug Class, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Class, 2022-2032

        5.3.1. Corticosteroids

        5.3.2. Antihistamines

        5.3.3. Antibiotics

    5.4. Y-o-Y Growth Trend Analysis By Drug Class, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Drug Class, 2022-2032

6. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Route of Administration, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2032

        6.3.1. Oral

        6.3.2. Topical

        6.3.3. Injectable

    6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Route of Administration, 2022-2032

7. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032

        7.3.1. Veterinary Pharmacies

        7.3.2. Retail Pharmacies

        7.3.3. Online Pharmacies

    7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021

    7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032

8. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia & Pacific

        8.3.6. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Drug Class

        9.2.3. By Route of Administration

        9.2.4. By Distribution Channel

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Drug Class

        9.3.3. By Route of Administration

        9.3.4. By Distribution Channel

    9.4. Key Takeaways

10. Latin America Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Mexico

            10.2.1.2. Brazil

            10.2.1.3. Rest of Latin America

        10.2.2. By Drug Class

        10.2.3. By Route of Administration

        10.2.4. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Drug Class

        10.3.3. By Route of Administration

        10.3.4. By Distribution Channel

    10.4. Key Takeaways

11. Europe Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. BENELUX

            11.2.1.7. Russia

            11.2.1.8. Rest of Europe

        11.2.2. By Drug Class

        11.2.3. By Route of Administration

        11.2.4. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drug Class

        11.3.3. By Route of Administration

        11.3.4. By Distribution Channel

    11.4. Key Takeaways

12. East Asia Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Drug Class

        12.2.3. By Route of Administration

        12.2.4. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Drug Class

        12.3.3. By Route of Administration

        12.3.4. By Distribution Channel

    12.4. Key Takeaways

13. South Asia & Pacific Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. ASEAN

            13.2.1.3. Australia and New Zealand

            13.2.1.4. Rest of South Asia & Pacific

        13.2.2. By Drug Class

        13.2.3. By Route of Administration

        13.2.4. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Drug Class

        13.3.3. By Route of Administration

        13.3.4. By Distribution Channel

    13.4. Key Takeaways

14. MEA Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. Turkey

            14.2.1.3. South Africa

            14.2.1.4. Rest of MEA

        14.2.2. By Drug Class

        14.2.3. By Route of Administration

        14.2.4. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Drug Class

        14.3.3. By Route of Administration

        14.3.4. By Distribution Channel

    14.4. Key Takeaways

15. Key Countries Feline Atopic Dermatitis Treatment Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Drug Class

            15.1.2.2. By Route of Administration

            15.1.2.3. By Distribution Channel

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Drug Class

            15.2.2.2. By Route of Administration

            15.2.2.3. By Distribution Channel

    15.3. Mexico

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Drug Class

            15.3.2.2. By Route of Administration

            15.3.2.3. By Distribution Channel

    15.4. Brazil

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Drug Class

            15.4.2.2. By Route of Administration

            15.4.2.3. By Distribution Channel

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Drug Class

            15.5.2.2. By Route of Administration

            15.5.2.3. By Distribution Channel

    15.6. Italy

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Drug Class

            15.6.2.2. By Route of Administration

            15.6.2.3. By Distribution Channel

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Drug Class

            15.7.2.2. By Route of Administration

            15.7.2.3. By Distribution Channel

    15.8. U.K.

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Drug Class

            15.8.2.2. By Route of Administration

            15.8.2.3. By Distribution Channel

    15.9. Spain

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Drug Class

            15.9.2.2. By Route of Administration

            15.9.2.3. By Distribution Channel

    15.10. BENELUX

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Drug Class

            15.10.2.2. By Route of Administration

            15.10.2.3. By Distribution Channel

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Drug Class

            15.11.2.2. By Route of Administration

            15.11.2.3. By Distribution Channel

    15.12. China

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Drug Class

            15.12.2.2. By Route of Administration

            15.12.2.3. By Distribution Channel

    15.13. Japan

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Drug Class

            15.13.2.2. By Route of Administration

            15.13.2.3. By Distribution Channel

    15.14. South Korea

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Drug Class

            15.14.2.2. By Route of Administration

            15.14.2.3. By Distribution Channel

    15.15. India

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Drug Class

            15.15.2.2. By Route of Administration

            15.15.2.3. By Distribution Channel

    15.16. ASEAN

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Drug Class

            15.16.2.2. By Route of Administration

            15.16.2.3. By Distribution Channel

    15.17. Australia and New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Drug Class

            15.17.2.2. By Route of Administration

            15.17.2.3. By Distribution Channel

    15.18. GCC Countries

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Drug Class

            15.18.2.2. By Route of Administration

            15.18.2.3. By Distribution Channel

    15.19. Turkey

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Drug Class

            15.19.2.2. By Route of Administration

            15.19.2.3. By Distribution Channel

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Drug Class

            15.20.2.2. By Route of Administration

            15.20.2.3. By Distribution Channel

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Drug Class

        16.3.3. By Route of Administration

        16.3.4. By Distribution Channel

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Bausch Health Companies Inc.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Bayer AG

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Pfizer Inc.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Novartis AG

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Eli Lily Company

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Sanofi

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Bristol-Myers Squibb Company

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Boehringer Ingelheim International GmbH

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 3: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 4: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 5: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 7: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 8: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 9: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 11: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 12: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 13: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 15: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 16: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 17: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 19: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 20: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 21: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 23: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 24: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 25: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 27: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 28: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 2: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 3: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 4: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 9: Global Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 10: Global Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 11: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 12: Global Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 13: Global Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 14: Global Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 15: Global Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 16: Global Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 17: Global Feline Atopic Dermatitis Treatment Market Attractiveness by Drug Class, 2022-2032

Figure 18: Global Feline Atopic Dermatitis Treatment Market Attractiveness by Route of Administration, 2022-2032

Figure 19: Global Feline Atopic Dermatitis Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 20: Global Feline Atopic Dermatitis Treatment Market Attractiveness by Region, 2022-2032

Figure 21: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 22: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 23: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 24: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 29: North America Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 30: North America Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 31: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 32: North America Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 33: North America Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 34: North America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 35: North America Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 36: North America Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 37: North America Feline Atopic Dermatitis Treatment Market Attractiveness by Drug Class, 2022-2032

Figure 38: North America Feline Atopic Dermatitis Treatment Market Attractiveness by Route of Administration, 2022-2032

Figure 39: North America Feline Atopic Dermatitis Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 40: North America Feline Atopic Dermatitis Treatment Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 42: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 43: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 44: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 49: Latin America Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 50: Latin America Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 51: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 52: Latin America Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 53: Latin America Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 54: Latin America Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 55: Latin America Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 56: Latin America Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 57: Latin America Feline Atopic Dermatitis Treatment Market Attractiveness by Drug Class, 2022-2032

Figure 58: Latin America Feline Atopic Dermatitis Treatment Market Attractiveness by Route of Administration, 2022-2032

Figure 59: Latin America Feline Atopic Dermatitis Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 60: Latin America Feline Atopic Dermatitis Treatment Market Attractiveness by Country, 2022-2032

Figure 61: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 62: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 63: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 64: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 69: Europe Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 70: Europe Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 71: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 72: Europe Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 73: Europe Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 74: Europe Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 75: Europe Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 76: Europe Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 77: Europe Feline Atopic Dermatitis Treatment Market Attractiveness by Drug Class, 2022-2032

Figure 78: Europe Feline Atopic Dermatitis Treatment Market Attractiveness by Route of Administration, 2022-2032

Figure 79: Europe Feline Atopic Dermatitis Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 80: Europe Feline Atopic Dermatitis Treatment Market Attractiveness by Country, 2022-2032

Figure 81: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 82: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 83: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 84: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 85: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: East Asia Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: East Asia Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 89: East Asia Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 90: East Asia Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 91: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 92: East Asia Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 93: East Asia Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 94: East Asia Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 95: East Asia Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 96: East Asia Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 97: East Asia Feline Atopic Dermatitis Treatment Market Attractiveness by Drug Class, 2022-2032

Figure 98: East Asia Feline Atopic Dermatitis Treatment Market Attractiveness by Route of Administration, 2022-2032

Figure 99: East Asia Feline Atopic Dermatitis Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 100: East Asia Feline Atopic Dermatitis Treatment Market Attractiveness by Country, 2022-2032

Figure 101: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 102: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 103: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 104: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 105: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 109: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 110: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 111: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 112: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 113: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 114: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 115: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 116: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 117: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Attractiveness by Drug Class, 2022-2032

Figure 118: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Attractiveness by Route of Administration, 2022-2032

Figure 119: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 120: South Asia & Pacific Feline Atopic Dermatitis Treatment Market Attractiveness by Country, 2022-2032

Figure 121: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 122: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 123: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 124: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 125: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 126: MEA Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 127: MEA Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 128: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 129: MEA Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 130: MEA Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 131: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 132: MEA Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 133: MEA Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 134: MEA Feline Atopic Dermatitis Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 135: MEA Feline Atopic Dermatitis Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 136: MEA Feline Atopic Dermatitis Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 137: MEA Feline Atopic Dermatitis Treatment Market Attractiveness by Drug Class, 2022-2032

Figure 138: MEA Feline Atopic Dermatitis Treatment Market Attractiveness by Route of Administration, 2022-2032

Figure 139: MEA Feline Atopic Dermatitis Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 140: MEA Feline Atopic Dermatitis Treatment Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Canine Atopic Dermatitis Treatment Market

Published : February 2022

Healthcare

Atopic Dermatitis Treatment Market

Published : January 2022

Google translate

Feline Atopic Dermatitis Treatment Market